Stay updated with breaking news from Developmental Therapeutics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study from UH Seidman Cancer Center and Case
Winship Cancer Institute of Emory University has been awarded a P01 program project grant from the National Cancer Institute (NCI), nearly $11 million dollars over five years, to support research aimed at improving the effectiveness of immunotherapy for lung cancer in patients.
The US National Cancer Institute (NCI) has long had programs to make available to researchers any variety of compounds, natural and synthetic. These offerings are administered by the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD).
Assistant professor Jason Cantor has received a 2021 Hartwell Individual Biomedical Research Award. His was among the ten award-winning proposals that represent early-stage, innovative and cutting-edge technology in medicine and biomedical engineering.
Dublin, Feb. 09, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Toxicity Testing: Technologies and Global Markets" report has been added to...